Australia markets open in 3 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
40.31-1.32 (-3.17%)
At close: 04:00PM EDT
40.31 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
9,434
18,437
32,166
Cost of revenue
0
-
-
-
-
Gross profit
3,500
-
-
-
-
Operating expenses
Research development
167,512
167,512
105,767
75,463
50,523
Selling general and administrative
46,542
46,542
32,810
21,967
12,944
Total operating expenses
214,054
214,054
138,577
97,430
63,467
Operating income or loss
-214,054
-214,054
-129,143
-78,993
-31,301
Interest expense
-
-
0
0
484
Total other income/expenses net
3,749
3,749
-4,825
-361
412
Income before tax
-182,685
-182,685
-125,255
-78,888
-29,094
Income tax expense
-292
-292
118
-6
-257
Income from continuing operations
-182,393
-182,393
-125,373
-78,882
-28,837
Net income
-182,393
-182,393
-125,373
-78,882
-28,837
Net income available to common shareholders
-182,393
-182,393
-124,936
-77,087
-28,013
Basic EPS
-2.66
-
-2.06
-1.77
-0.81
Diluted EPS
-2.66
-
-2.06
-1.77
-0.81
Basic average shares
65,811
-
60,542
43,627
34,542
Diluted average shares
65,811
-
60,542
43,627
34,542